Trials / Unknown
UnknownNCT03804736
Fecal Microbiota Transplant by Oral Capsules With Lactobacilli for Recurrent Clostridium Difficile Infection
Fecal Microbiota Transplant by Oral Capsules Enriched With Lactobacilli for Recurrent Clostridium Difficile Infection
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 21 (actual)
- Sponsor
- Universidad Autonoma de Nuevo Leon · Academic / Other
- Sex
- —
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Investigators designed an open, two-arm study to compare fecal microbiota transplant by oral capsules (FMT-c ) versus FMT-c enriched with Lactobacillus for treatment of C. difficile recurrent infection
Detailed description
Investigators designed an open, two-arm study to compare to compare fecal microbiota transplant by oral capsules (FMT-c ) versus FMT-c enriched with Lactobacillus for treatment of C. difficile recurrent infection. From each patient, a fecal sample was obtained at days 0, 3, and 7 after treatment. Fecal samples are analyzed by 16 subunit ribosomal ribonucleic acid (16S rRNA) metagenomic sequencing.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | FMT-c | Patients in the FMT-c receive FMT-c (15 capsules every 12 h for 2 days) |
| BIOLOGICAL | FMT-c Lactobacillus | Patients in the FMT-c Lactobacillus receive FMT-c Lactobacillus (15 capsules every 12 h for 2 days) |
Timeline
- Start date
- 2016-11-01
- Primary completion
- 2018-06-30
- Completion
- 2019-12-01
- First posted
- 2019-01-15
- Last updated
- 2019-03-05
Source: ClinicalTrials.gov record NCT03804736. Inclusion in this directory is not an endorsement.